KALY Kali Inc.

Kali, Inc. Provides Shareholder Update

Kali, Inc. Provides Shareholder Update

Sarasota, Florida, June 28, 2018 (GLOBE NEWSWIRE) -- Kali, Inc. (USOTC: KALY) issued the following shareholder update today from its Chairman and CEO, Charles Yawn:  

Dear Shareholders,

I am pleased to share with you today an update on recent corporate developments and our vision for the future of Kali, Inc.  First, I wish to take this opportunity to thank all our shareholders for your continued support and commitment.  We have been quiet recently as we have been focused on evaluating opportunities to drive growth in our current $5 billion fragmented and underserved marina market sector.  Our primary focus is on achieving profitability and driving shareholder value. 

We are well-aligned to continue our growth in the marina services industry but as we view the landscape of our existing business line, we believe that we can achieve accelerated revenue growth by expanding our business operations through the numerous growth opportunities available to us.  To that end, we have been analyzing further opportunities relating to marine asset acquisitions, marina management, and a spinoff marine canvas division.  We are evaluating each possibility for fit and value and look forward to reporting progress as we proceed.    

We have recently filed our annual report with the state of Nevada and are working to become compliant with OTC Markets for a current pink sheet listing.  We are also working on a new corporate website which we are hoping to publish in the near future. 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT:
Kali, Inc.
941.444.6994
 
EN
28/06/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kali Inc.

 PRESS RELEASE

CORRECTION FROM SOURCE: KALY Exits Cannabis Business With Shareholder ...

This document corrects and replaces the press release that was issued by Kali Inc. (OTC Pink: KALY) (“KALY”) today July 16, 2020 at 11:24 am ET. The release below replaces the entirety of the previous release, as the incorrect release was sent.The corrected press release follows in full below:Dallas, Texas--(Newsfile Corp. - July 16, 2020) - Kali, Inc. (OTC Pink: KALY) ("KALY") today announced a deal in the works to sell its cannabis execration subsidiary, NCM Biotech, to PAO Group, Inc. (OTC Pink: PAOG) in exchange for common shares of PAOG that will in turn be issued to KALY shareholders in ...

 PRESS RELEASE

KALY Calls for Partners on Patented Technology and Potential COVID-19 ...

Dallas, Texas--(Newsfile Corp. - July 16, 2020) - Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) ("KALY") today issued a call for potential partners that could contribute to the acceleration of evaluating and developing KALY's proprietary CBD formulation developed for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. Researchers believe the CBD formulation could be effective in the treatment of symptoms resulting from COVID-19.The formulation for the treatment of symptoms associated with C...

 PRESS RELEASE

KALY Previews Investment Commitment Into Its Cannabis Biopharmaceutica...

Dallas, Texas--(Newsfile Corp. - February 3, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY"), today previewed a Letter of Intent (LOI) executed with a third-party investor. The LOI details are anticipated to be released tomorrow. Management indicates the two-stage investment is of substantial magnitude and can meaningfully advance the company's ongoing development of its cannabis biopharmaceutical technology. KALY has a U.S. Patented Cannabis Extraction Process it uses to produce proprietary formulations for the treatment of various medical conditi...

 PRESS RELEASE

KALY Patented Cannabis Biotech $50 Million Valuation Supported By Anal...

Dallas, Texas--(Newsfile Corp. - January 31, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today pointed to a on the legal marijuana market projecting the legal marijuana market to reach over $66 Billion in value by 2025 to support a recent $50 Million valuation of KALY's cannabis biotechnology. KALY has U.S. Patented Cannabis Extraction Process it uses to produce proprietary formulations for the treatment of various medical conditions. Grand View Research indicates the growing adoption of cannabis as a pharmaceutical is a substantial driver be...

 PRESS RELEASE

KALY- Kali-Extracts Proprietary CBD Extract Could Offer Coronavirus Re...

Dallas, Texas--(Newsfile Corp. - January 29, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today confirmed efforts to evaluate its proprietary CBD extract formulation as a treatment for coronavirus symptoms. KALY's proprietary CBD formulation has been developed for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The formulation for the treatment of symptoms associated with COPD and other similar respiratory conditions has been derived from the company's U.S. Patented...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch